James Bowie - Invizyne Technologies Founder Director
| IZTC Stock | 12.60 0.87 6.46% |
Director
James Bowie is Founder Director of Invizyne Technologies Common
| Age | 63 |
| Address | 750 Royal Oaks Drive, Monrovia, CA, United States, 91016 |
| Phone | 626 415 1488 |
| Web | https://www.invizyne.com |
James Bowie Latest Insider Activity
Tracking and analyzing the buying and selling activities of James Bowie against Invizyne Technologies stock is an integral part of due diligence when investing in Invizyne Technologies. James Bowie insider activity provides valuable insight into whether Invizyne Technologies is net buyers or sellers over its current business cycle. Note, Invizyne Technologies insiders must abide by specific rules, including filing SEC forms every time they buy or sell Invizyne Technologies'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
James Bowie over a week ago Insider Trading | ||
James Bowie over two weeks ago Insider Trading |
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Raymond Lo | ASE Industrial Holding | 64 | |
| Tien Wu | ASE Industrial Holding | 66 | |
| John Losh | Cardinal Health | 73 | |
| Rutherford Chang | ASE Industrial Holding | 44 | |
| Joseph Tung | ASE Industrial Holding | 65 | |
| C Ford | SunLink Health Systems | 79 | |
| Karen Brenner | SunLink Health Systems | 63 | |
| Shengfu You | ASE Industrial Holding | 74 | |
| TienSzu Chen | ASE Industrial Holding | 59 | |
| Christopher Mills | SunLink Health Systems | 67 | |
| TaLin Hsu | ASE Industrial Holding | 75 | |
| MeiYueh Ho | ASE Industrial Holding | 69 | |
| Akhil Johri | Cardinal Health | 59 | |
| Carrie Cox | Cardinal Health | 62 | |
| Howard Turner | SunLink Health Systems | 76 | |
| Calvin Darden | Cardinal Health | 69 | |
| Gene Burleson | SunLink Health Systems | 77 | |
| Nancy Killefer | Cardinal Health | 66 | |
| Steven Baileys | SunLink Health Systems | 64 | |
| Patricia Hall | Cardinal Health | 67 | |
| Bruce Downey | Cardinal Health | 72 | |
Invizyne Technologies Leadership Team
Elected by the shareholders, the Invizyne Technologies' board of directors comprises two types of representatives: Invizyne Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Invizyne. The board's role is to monitor Invizyne Technologies' management team and ensure that shareholders' interests are well served. Invizyne Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Invizyne Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tyler Korman, CoFounder Research | ||
| Paul Opgenorth, CoFounder Development | ||
| Michael Heltzen, Chief Officer | ||
| Fouad Nawaz, Vice Finance | ||
| Mohammad JD, Chairman CoFounder | ||
| Zachary Karl, VP Development | ||
| James Bowie, Founder Director | ||
| Michael Burns, Executive Transition | ||
| Lasse Gorlitz, Vice Communications |
Invizyne Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Invizyne Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Invizyne Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Invizyne Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Invizyne Technologies Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Invizyne Technologies Common Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Invizyne Technologies Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Invizyne Technologies. If investors know Invizyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Invizyne Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Invizyne Technologies is measured differently than its book value, which is the value of Invizyne that is recorded on the company's balance sheet. Investors also form their own opinion of Invizyne Technologies' value that differs from its market value or its book value, called intrinsic value, which is Invizyne Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Invizyne Technologies' market value can be influenced by many factors that don't directly affect Invizyne Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Invizyne Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Invizyne Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Invizyne Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.